Histone Deacetylase Inhibition Enhances Radiation Sensitivity in Colorectal Cancer Cells
Author Information
Author(s): Flatmark Kjersti, Nome Ragnhild V, Folkvord Sigurd, Bratland Åse, Rasmussen Heidi, Ellefsen Mali Strand, Fodstad Øystein, Ree Anne Hansen
Primary Institution: Rikshospitalet-Radiumhospitalet Medical Center, University of Oslo
Hypothesis
Can histone deacetylase inhibitors enhance the radiosensitivity of colorectal carcinoma cell lines?
Conclusion
Histone deacetylase inhibition sensitized colorectal cancer cells to ionizing radiation, increasing the likelihood of tumor cell death.
Supporting Evidence
- HDAC inhibitors caused hyperacetylation of histones, leading to chromatin remodeling.
- Cell lines with intact p53 showed different cell cycle responses compared to those with defective p53.
- Clonogenicity was significantly reduced in cells pre-treated with HDAC inhibitors before radiation exposure.
- Histone acetylation was associated with increased tumor cell death following radiation.
Takeaway
This study found that using certain drugs can make cancer cells more sensitive to radiation, helping to kill them more effectively.
Methodology
Colorectal carcinoma cell lines were treated with HDAC inhibitors and exposed to ionizing radiation, followed by analysis of cell cycle profiles and clonogenicity.
Potential Biases
Potential bias in the selection of cell lines and treatment concentrations.
Limitations
The study was conducted in vitro, and results may not fully translate to in vivo conditions.
Participant Demographics
Human colorectal carcinoma cell lines with varying p53 status.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website